A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis
Clinical trial NCT03329885 · TERMINATED
Trial details
- NCT number
- NCT03329885
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-02
- Primary completion
- 2018-06-26
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.